Sonolisib

≥99%

  • Product Code: 124854
  CAS:    502632-66-8
Molecular Weight: 525.59 g./mol Molecular Formula: C₂₉H₃₅NO₈
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: -20°C, dry, sealed
Product Description: Sonolisib is primarily used in the field of oncology as a targeted therapy for cancer treatment. It functions as a PI3K inhibitor, specifically targeting the PI3K/mTOR pathway, which is often dysregulated in various cancers. By inhibiting this pathway, it helps to reduce tumor growth and proliferation. It is being investigated for its potential in treating solid tumors and hematologic malignancies, particularly in cases where traditional therapies have shown limited efficacy. Additionally, its role in clinical trials focuses on evaluating its safety, tolerability, and effectiveness in combination with other anticancer agents.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.001 10-20 days €1,111.45
+
-
Sonolisib
Sonolisib is primarily used in the field of oncology as a targeted therapy for cancer treatment. It functions as a PI3K inhibitor, specifically targeting the PI3K/mTOR pathway, which is often dysregulated in various cancers. By inhibiting this pathway, it helps to reduce tumor growth and proliferation. It is being investigated for its potential in treating solid tumors and hematologic malignancies, particularly in cases where traditional therapies have shown limited efficacy. Additionally, its role in clinical trials focuses on evaluating its safety, tolerability, and effectiveness in combination with other anticancer agents.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: €0.00
€0.00 Total :